Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...

The FDA approved pembrolizumab (Keytruda) for patients with PD-L1-positive resectable locally advanced head and neck squamous ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...

Step-and-shoot SPArc therapy reduces radiation to critical areas in head and neck tumours, showing promising results.

Artificial intelligence (AI) tools such as deep learning-based algorithms can be valuable as previous studies have shown a reduction in contouring time and variation. Furthermore, explainable AI (XAI) ...

That radiant glow you’re chasing by soaking up the sun could be doing more harm than good by raising your risk for skin ...

Hamad Medical Corporation (HMC) hosted its inaugural Patient Awareness Programme, “Enhancing the Quality of Life of Patients ...

A nurse was awarded an MBE in the 2025 King’s Birthday Honours because of her ‘truly inspiring’ work with patients.